Julian Fink
Overview
Explore the profile of Julian Fink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klein T, Gruner J, Breyer M, Schlegel J, Schottmann N, Hofmann L, et al.
Brain Commun
. 2024 Apr;
6(2):fcae095.
PMID: 38638148
Acral burning pain triggered by fever, thermal hyposensitivity and skin denervation are hallmarks of small fibre neuropathy in Fabry disease, a life-threatening X-linked lysosomal storage disorder. Variants in the gene...
2.
Sternstein C, Bohm T, Fink J, Meyr J, Ludemann M, Krug M, et al.
Bioconjug Chem
. 2023 Sep;
34(10):1923.
PMID: 37713650
No abstract available.
3.
Sternstein C, Bohm T, Fink J, Meyr J, Ludemann M, Krug M, et al.
Bioconjug Chem
. 2023 Jun;
34(7):1221-1233.
PMID: 37328799
The glycosylation of cellular membranes is crucial for the survival and communication of cells. As our target is the engineering of the glycocalyx, we designed a functionalized lipid anchor for...
4.
Brenner D, Geiger N, Schlegel J, Diesendorf V, Kersting L, Fink J, et al.
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108461
Recently, we have shown that C6-ceramides efficiently suppress viral replication by trapping the virus in lysosomes. Here, we use antiviral assays to evaluate a synthetic ceramide derivative α-NH2-ω-N3-C6-ceramide (AKS461) and...
5.
Messerli M, Fink J, Reuter K
Synthese
. 2022 Aug;
200(5):365.
PMID: 36043218
Weakness of the will remains a perplexing issue. Though philosophers have made substantial progress in homing in on what counts as a weak will, there is little agreement on whether...
6.
Eder S, Hollmann C, Mandasari P, Wittmann P, Schumacher F, Kleuser B, et al.
J Funct Biomater
. 2022 Aug;
13(3).
PMID: 35997449
A fine balance of regulatory (T) and conventional CD4 T cells (T) is required to prevent harmful immune responses, while at the same time ensuring the development of protective immunity...
7.
Wiese T, Dennstadt F, Hollmann C, Stonawski S, Wurst C, Fink J, et al.
Brain Commun
. 2021 Apr;
3(2):fcab020.
PMID: 33898989
Genetic deficiency for acid sphingomyelinase or its pharmacological inhibition has been shown to increase Foxp3 regulatory T-cell frequencies among CD4 T cells in mice. We now investigated whether pharmacological targeting...
8.
Peters S, Kaiser L, Fink J, Schumacher F, Perschin V, Schlegel J, et al.
Sci Rep
. 2021 Feb;
11(1):4300.
PMID: 33619350
Sphingolipids, including ceramides, are a diverse group of structurally related lipids composed of a sphingoid base backbone coupled to a fatty acid side chain and modified terminal hydroxyl group. Recently,...
9.
Rajeeve K, Vollmuth N, Janaki-Raman S, Wulff T, Baluapuri A, Dejure F, et al.
Nat Microbiol
. 2021 Feb;
6(4):533.
PMID: 33589805
No abstract available.
10.
Fink J, Schumacher F, Schlegel J, Stenzel P, Wigger D, Sauer M, et al.
Org Biomol Chem
. 2021 Jan;
19(10):2203-2212.
PMID: 33496698
Here were report the combination of biocompatible click chemistry of ω-azidosphinganine with fluorescence microscopy and mass spectrometry as a powerful tool to elaborate the sphingolipid metabolism. The azide probe was...